Asia Pacific Bovine Respiratory Disease Treatment Market Research Report - By Type of Treatment and Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends, Forecast (2024 to 2029)
APAC Bovine Respiratory Disease Treatment Market Size (2024 to 2029)
The Asia Pacific Bovine Respiratory Disease Treatment Market was estimated at USD 30.77 million in 2024. It is further projected to reach USD 114.47 million by 2029, growing at a CAGR of 30.05% during the forecast period. In the Asia Pacific region, China and India have greater cattle adoption and are expected to grow fast.
BRD is more than just a disease. It’s a respiratory disease complex that combines disease organisms with management and environmental stressors. There are several built-in stressors such as transition stress, feed changes, and environmental exposures. These stressors combine with disease organisms and advance into a complex that challenges an animal’s health.
In the current scenario, cattle producers are trying to maximize the performance of each animal. Bovine respiratory disease (BRD) is a challenge to all cattle producers. There are many types of infectious agents involved. These agents not only cause severe pneumonia but also swollen, painful joints in calves.
This research report segmented and sub-segmented the Asia Pacific Bovine Respiratory Disease Treatment Market into the following categories.
By Treatment Type
- Anti-Infectious Agents
- Antibiotics
- Sulfates
- Anti-Parasiticides
- Bronchodilators
- Oral Rehydration Fluids
- Non-Steroidal Anti-Inflammatories
- Mucolytics
By Country
- India
- China
- Japan
- South Korea
- Australia
- New Zealand
- Thailand
- Malaysia
- Vietnam
- Philippines
- Indonesia
- Singapore
- Rest of APAC
Notable companies leading the APAC Bovine Respiratory Disease Treatment Market are Zoetis Inc., Merck & Co. Inc., Bayer Corporation, Eli Lilly & Co, Merial S.A.S, Boehringer Ingelheim Vetmedica, Novartis Animal Health, Vibrac S.A., Ceva Sante Animale, and Vétoquinol S.A.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]